Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Apatinib> ?p ?o. }
Showing items 1 to 49 of
49
with 100 items per page.
- Apatinib abstract "Apatinib, also known as YN968D1, is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2 (VEGFR2, also known as KDR). It is an orally bioavailable, small molecule agent which is thought to inhibit angiogenesis in cancer cells; specifically apatinib inhibits VEGF-mediated endothelial cell migration and proliferation thus blocking new blood vessel formation in tumor tissue. This agent also mildly inhibits c-Kit and c-SRC tyrosine kinases.Apatinib was first synthesized by Advenchen Laboratories in California, USA and is being developed by Jiangsu Hengrui Medicine (China), LSK BioPartners (US) and Bukwang Pharmaceutical Company (Korea). It is an investigational cancer drug currently undergoing clinical trials as a potential targeted treatment for metastatic gastric carcinoma, metastatic breast cancer and advanced hepatocellular carcinoma.".
- Apatinib atcPrefix "none".
- Apatinib iupacName "N-[4-(1-cyanocyclopentyl) phenyl-2-(4-picolyl)amino-3-Nicotinamide methanesulphonate]".
- Apatinib thumbnail Apatinib.svg?width=300.
- Apatinib wikiPageID "24682338".
- Apatinib wikiPageRevisionID "591475840".
- Apatinib atcPrefix "none".
- Apatinib c "25".
- Apatinib chemspiderid "26286870".
- Apatinib h "27".
- Apatinib hasPhotoCollection Apatinib.
- Apatinib inchi "1".
- Apatinib inchikey "BDGPIQYIFFSTGI-UHFFFAOYAV".
- Apatinib iupacName "N-[4- phenyl-2-amino-3-Nicotinamide methanesulphonate]".
- Apatinib molecularWeight "493.58".
- Apatinib n "5".
- Apatinib o "3".
- Apatinib routesOfAdministration "Oral".
- Apatinib s "1".
- Apatinib smiles "Cc1ccncc1[NH2+]c2cCNc3cccC4C#N.CS[O-]".
- Apatinib stdinchi "1".
- Apatinib stdinchikey "BDGPIQYIFFSTGI-UHFFFAOYSA-N".
- Apatinib verifiedrevid "459713760".
- Apatinib subject Category:Experimental_cancer_drugs.
- Apatinib subject Category:Tyrosine_kinase_inhibitors.
- Apatinib type Agent114778436.
- Apatinib type Antineoplastic102722458.
- Apatinib type CausalAgent100007347.
- Apatinib type CytotoxicDrug103157987.
- Apatinib type Drug103247620.
- Apatinib type ExperimentalCancerDrugs.
- Apatinib type Matter100020827.
- Apatinib type Medicine103740161.
- Apatinib type PhysicalEntity100001930.
- Apatinib type Substance100020090.
- Apatinib type TyrosineKinaseInhibitor104506005.
- Apatinib type TyrosineKinaseInhibitors.
- Apatinib type Drug.
- Apatinib type DrugProduct.
- Apatinib type FunctionalSubstance.
- Apatinib comment "Apatinib, also known as YN968D1, is a tyrosine kinase inhibitor that selectively inhibits the vascular endothelial growth factor receptor-2 (VEGFR2, also known as KDR). It is an orally bioavailable, small molecule agent which is thought to inhibit angiogenesis in cancer cells; specifically apatinib inhibits VEGF-mediated endothelial cell migration and proliferation thus blocking new blood vessel formation in tumor tissue.".
- Apatinib label "Apatinib".
- Apatinib sameAs m.080b8xl.
- Apatinib sameAs Q4779233.
- Apatinib sameAs Q4779233.
- Apatinib sameAs Apatinib.
- Apatinib wasDerivedFrom Apatinib?oldid=591475840.
- Apatinib depiction Apatinib.svg.
- Apatinib isPrimaryTopicOf Apatinib.
